Page 225 - Safety Risk Management for Medical Devices
P. 225

204   Safety Risk Management for Medical Devices


                26.1 TERMINOLOGY
                In the following sections references are made to the following terms. It is important to
                understand the language of clinical investigations and be able to distinguish the terms.
                   Adverse Device Effect (ADE): “Adverse event related to the use of an investigational
                medical device” ([33] 3.1).
                   Adverse Event (AE): “Any untoward medical occurrence, unintended disease or injury,
                or untoward clinical signs (including abnormal laboratory findings) in subjects, users or
                other persons, whether or not related to the investigational medical device” ([33] 3.2).
                   Clinical Evaluation: A methodologically sound ongoing procedure to collect,
                appraise and analyze clinical data pertaining to a medical device, and to evaluate
                whether there is sufficient clinical evidence to confirm compliance with relevant
                essential requirements for safety and performance when using the device according to
                the manufacturer’s Instructions for Use [32].
                   Clinical Investigation: Systematic investigation in one or more human subjects,
                undertaken to assess the safety or performance of a medical device ([33] 3.6).
                   Clinical Investigation Plan (CIP): Document that states the rationale, objectives,
                design and proposed analysis, methodology, monitoring, conduct and record-keeping
                of the clinical investigation ([33] 3.7).
                   Investigator’s Brochure (IB): Compilation of the current clinical and non-clinical
                information on the investigational medical device(s), relevant to the clinical investiga-
                tion ([33] 3.25).
                   Serious Adverse Device Effect (SADE): Adverse device effect that has resulted in any
                of the consequences characteristic of a serious adverse event ([33] 3.36).
                   Serious Adverse Event (SAE): Adverse event that

                   a. led to death,
                   b. led to serious deterioration in the health of the subject, that either resulted in
                      1. a life-threatening illness or injury, or
                      2. a permanent impairment of a body structure or a body function, or
                      3. in-patient or prolonged hospitalization, or
                      4. medical or surgical intervention to prevent life-threatening illness or injury
                         or permanent impairment to a body structure or a body function,
                   c. led to fetal distress, fetal death or a congenital abnormality or birth defect ([33]
                      3.37)

                   Ref. [33] also notes that the terms “Clinical trial” or “clinical study” are synony-
                mous with “clinical investigation.”


                26.2 CLINICAL STUDIES
                Before we discuss the requirements of risk management for clinical studies, it is
                important to understand the different types of clinical studies.
   220   221   222   223   224   225   226   227   228   229   230